Importance Lipoprotein (a)(Lp [a]) is a low-density lipoprotein (LDL) cholesterol–like particle
bound to apolipoprotein (a). This novel marker of cardiovascular disease acts through …

Inflammation and oxidative stress conditions lead to a variety of oxidative modifications of
lipoprotein phospholipids implicated in the occurrence and development of atherosclerotic …

Background Data support lipoprotein (a)(Lp [Lp (a)]) being a risk factor for atherosclerotic
cardiovascular disease (ASCVD). Olpasiran is a small interfering RNA molecule that …

Lipid-and lipoprotein-modifying therapies have expanded substantially in the last 25 years,
resulting in reduction in the incidence of major adverse cardiovascular events. However, no …

Lipoprotein (a)[Lp (a)] is a well-established risk factor for cardiovascular disease,
predisposing to major cardiovascular events, including coronary heart disease, stroke, aortic …

Abstract Purpose of Review The goal of this review is to present the pharmacodynamic
effectiveness as well as the clinical efficacy and safety of investigational antisense …

Lipoprotein (a)(Lp (a)) molecule includes two protein components: apolipoprotein (a) and
apoB100. The molecule is the main transporter of oxidized phospholipids (OxPL) in plasma …

Cardiovascular disease (CVD) still being the most common cause of death in worldwide. In
spite of development of new lipid-lowering therapies which optimize low-density lipoprotein …

Cardiovascular disease (CVD) is still a leading cause of morbidity and mortality, despite all
the progress achieved as regards to both prevention and treatment. Having high levels of …

The cancer secretome comprises factors secreted by tumors, including cytokines, growth
factors, proteins from the extracellular matrix (ECM), proteases and protease inhibitors …